Alzheimers (Matisse) Flashcards
Dementia
Loss of cognitive function
- symptoms changes in personality, mood, behavior, memory loss
- irreversible (disease/injury) or reversible (drug/toxin/vitamin/depression)
Neurodegenerative Dementias (4)
Alzheimer’s Disease
Frontotemporal Dementia (Picks Disease)
Lewy Body Dementia
Creutzfeld-Jakob Disease
Dementia (mechanism, proteins for each)
-abnormal protein aggregation in neural tissue disrupts function AD: Amyloid ß-42 Frontotemporal Dementia: Tau LBD: å-synuclein CJD: prions
Dementia (genetics- susceptibility genes for each)
AD: Apolipoprotein E4
FTD: ?
LBD: Apolipoprotein E4
CJD: Prion
Alzheimers Symptoms/progression
Degenerative dementia starting with recent (episodic) memory deficit- motor, alertness fine
Anosmia: early indicator
5-10yr life expectancy
Neuritic Plaques
extracellular deposits of ß-amyloid protein, immune inflammatory response causes plaques since thinks it’s foreign. Constant inflammation causes neurodegeneration.
Amyloid ß Protein production (pathway)
Amyloid Precursor Protein (APP) gets cleaved by å or ß secretases, then those products by gamma secretases. ß pathway produces Amyloid ß protein (Aß-42), so pro-amyloidogenic. å pathway isnt.
ApoE4
this mutant form of lipoprotein predisposes risk of AD- impairs Aß-42 clearance
Aß-42 Oligomer Toxicity Hypothesis
Plaques correlated with AD, but really not necessary or sufficient. Real culprit is Aß-42 oligomers that can have neurotoxic effects
-affect NMDA and Ca channels impairing signal conductance, affect cytoskeleton via LilrB2 receptor
Neurofibrillary Tangles
intracellular accumulations of hyperphosphorylated Tau protein in AD, impairing proper axonal transport
- assocation with AD unclear, prob Aß downstream effect
- But Tau issue alone can be Frontotemporal Dementia
Diagnosing AD
-Hx (1% AD familial)
-Mental status exam
-smell test (anosmia=early sign)
-PET amyloid scan (PIB tracer for plaques)
Aß-42 levels: low = bad since bound in plaques
Tau: high = bad since means neurodegeneration is dumping it from deteriorating cells
AD Differential
Head Trauma
HIV
Huntingtons, Parkinsons, Picks (similar but motor involvement)
Vascular Dementia
Wernicke Korsakoff (alcoholism/B1 deficiency, reversible)
AD Treatment
- AChesterase inhibitors (since basal ganglia affected in AD, less ACh)
- NMDA Antagonists (protect brain from glutamate excitotoxicity)
Both just treat symptoms not disease
-future stuff should target ß-secretase, Aß-42. Or antiinflammatory, antioxidants